Christopher Sagers is Professor of Law at Cleveland State Univeristy. He has taught courses in Antitrust, Banking Regulation, Business Organizations, Law & Economics and Administrative Law. His scholarship focuses on antitrust and business regulation. Before joining the faculty, Professor Sagers practiced law for four years in Washington, D.C., first at Arnold & Porter and then at Shea & Gardner.
241
North Carolina Dentists is in the Hizzouse, Y’all ! Woot Woot !* So, the only real surprise about yesterday’s opinion in North Carolina State Bd of Dental Examiners v. FTC is that it wasn’t unanimous. The strongly worded six-member majority opinion, already receiving early applause (see here and (...)
483
Just What on Earth Did Actavis Really Say ? And Does It Mean Something for Section 1 More Broadly ?* It’s going to be a strict, nearly-per-se quick look rule, folks, in more or less every reverse-payment case likely to be brought from here on out. Dollars-to-donuts. A few weeks have gone by, (...)
305
Phoebe Putney : A Quick Post-Mortem, and Some Thoughts on the Next Justice Stevens* I often feel a certain deflation after the Supreme Court decides an antitrust case. After watching a case for months, prognosticating about it with other antitrusters, reading umpteen blog posts, reading the (...)
164
Federal Trade Commission Approves Universal-EMI* On September 21, 2012 the FTC announced that it had closed its investigation of Universal Music Group’s acquisition of EMI’s recorded music division. The Commission will not seek any concessions or take other action. Elsewhere I’ve written and (...)
366
Seventh Circuit Sitting En Banc Reverses in Potash, Announces Second Most Important of All FTAIA Opinions, Shores Up the Text Messaging Position on Conspiracy Pleading* Well, okay, I guess there might just possibly have been an appellate decision this week of even more pressing moment, but I (...)
340
Potash Potash Potash !!!!! En Banc Review Is in the Hizz-ouse, Y’all !* Something striking occurred in the Seventh Circuit this year. In two different, massive antitrust class actions, in the space of about nine months, panels of that court applied the Twombly-Iqbal pleading formula to reach (...)
558
FTC v. Lundbeck : Why, God, Why ?* What really has the world come to when a merger to monopoly followed by a 1300% price increase survives Section 7 challenge ? That, sadly, seems to be the final result in Federal Trade Commission v. Lundbeck, which the Eighth Circuit affirmed last Friday. (...)
166
North Carolina Dentists and the FTC’s Anti-Exemptions Mission : Is Antitrust Consistent With Democracy ? (Yes, actually. It is.)* Some commentators are pretty alarmed over the Federal Trade Commission’s ruling earlier this year denying antitrust immunity for a North Carolina regulatory board’s (...)
580
Some Reflections on the Lundbeck Appeal : Will Pharmaceuticals Get a Blanket Antitrust Immunity ? And Is Quality Competition No Longer Protected by Antitrust ?* A decision to watch for this year is the Eighth Circuit’s pending consideration of FTC v. Lundbeck, Inc., 2010-2 Trade Cases ¶77,160 ; (...)
267
Cette rubrique Livres recense et commente les ouvrages et autres publications en droit de la concurrence, droit & économie de la concurrence et en droit de la régulation. Une telle recension ne peut par nature être exhaustive et se limite donc à présenter quelques publications récentes dans ces (...)
28
Cette rubrique Livres recense et commente les ouvrages et autres publications en droit de la concurrence, droit & économie de la concurrence et en droit de la régulation. Une telle recension ne peut par nature être exhaustive et se limite donc à présenter quelques publications récentes dans ces (...)
9625
Ce dossier Concurrences se concentre sur l’antitrust et ses possibles développements à la suite des élections présidentielles américaines. Il s’interroge sur les changements et défis attendus pour 2021 sous la nouvelle administration Biden, et leurs impacts sur la législation et la politique de la (...)
Prix
230,00 €
Albert A. Foer Liber Amicorum
19 avenue Jean Aicard
75011 Paris, France
106 West 32nd Street, Suite 149
New York, NY, 10001, USA
563 Chiswick High Road
W4 3AY London, UK
